TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Donanemab exposure-response in early symptomatic Alzheimer's disease.

Ivelina Gueorguieva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.